Literature DB >> 30190835

Dynamic tumor heterogeneity in melanoma therapy: how do we address this in a novel model system?

Nikolas K Haass.   

Abstract

Entities:  

Keywords:  cancer drug resistance; fluorescent ubiquitination-based cell cycle indicator; invasion; melanoma heterogeneity; migration; real-time imaging; tumor microenvironment

Year:  2015        PMID： 30190835      PMCID： PMC6094608          DOI： 10.2217/mmt.15.1

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN： 2045-0885


× No keyword cloud information.
  21 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Melanoma: from mutations to medicine.

Authors:  Hensin Tsao; Lynda Chin; Levi A Garraway; David E Fisher
Journal:  Genes Dev       Date:  2012-06-01       Impact factor: 11.361

3.  Melanocytes: from morphology to application.

Authors:  A Santiago-Walker; L Li; N K Haass; M Herlyn
Journal:  Skin Pharmacol Physiol       Date:  2009-02-04       Impact factor: 3.479

4.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

5.  A stress-induced early innate response causes multidrug tolerance in melanoma.

Authors:  D Ravindran Menon; S Das; C Krepler; A Vultur; B Rinner; S Schauer; K Kashofer; K Wagner; G Zhang; E Bonyadi Rad; N K Haass; H P Soyer; B Gabrielli; R Somasundaram; G Hoefler; M Herlyn; H Schaider
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

6.  Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Authors:  Suzanne Carreira; Jane Goodall; Laurence Denat; Mercedes Rodriguez; Paolo Nuciforo; Keith S Hoek; Alessandro Testori; Lionel Larue; Colin R Goding
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

Review 7.  Melanoma's connections to the tumour microenvironment.

Authors:  Johanna M Brandner; Nikolas K Haass
Journal:  Pathology       Date:  2013-08       Impact factor: 5.306

Review 8.  Drug penetration in solid tumours.

Authors:  Andrew I Minchinton; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

9.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

Review 10.  Modeling Melanoma In Vitro and In Vivo.

Authors:  Kimberley A Beaumont; Nethia Mohana-Kumaran; Nikolas K Haass
Journal:  Healthcare (Basel)       Date:  2013-12-23
View more
  3 in total

1.  Therapeutic implications of melanoma heterogeneity.

Authors:  Stephanie J Hachey; Alexander D Boiko
Journal:  Exp Dermatol       Date:  2016-05-19       Impact factor: 3.960

2.  Low-metastatic melanoma cells acquire enhanced metastatic capability via exosomal transfer of miR-199a-1-5p from highly metastatic melanoma cells.

Authors:  Qiting Zhao; Hao Chen; Xiaoshuang Li; Bin Zeng; Zhiwei Sun; Doudou Liu; Yuting Chen; Yuhan Zhang; H Rosie Xing; Jianyu Wang
Journal:  Cell Death Discov       Date:  2022-04-09

3.  Melanoma stem cells promote metastasis via exosomal miR-1268a inactivation of autophagy.

Authors:  Doudou Liu; Yuhan Zhang; Xiaoshuang Li; Hao Chen; Bin Zeng; Qiting Zhao; Yuting Chen; Jianyu Wang; H Rosie Xing
Journal:  Biol Res       Date:  2022-10-01       Impact factor: 7.634
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.